Pyxis Oncology, Inc. (PYXS)

Market Closed

1 Sep, 20:00

NASDAQ (NGS)

3. 44

+0.2

+6.1728%

After Hours

3. 54

+0.1 +2.907%

205.27M Market Cap

- P/E Ratio

- Div Yield

589,146 Volume

-0.91 Eps

$ 3.24

Previous Close

Investors:

Day Range

3.17 3.57

Year Range

1.03 5.55

Want to track PYXS and more in your Portfolio? 🎯

Pyxis Oncology, Inc. Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
Madelyn D. Purcell Pfizer Inc	7.03M	$10.97M	$22.36M	$11.39M	103.85%
BZ Brandon Zatopek Commonwealth Equity Services LLC	42,455	$80,664.5	$158,357.15	$77,692.65	96.32%
Loryn J. Mischke University Of Chicago	48,731	$65,300	$146,680.31	$81,380.31	124.63%
Point72 Asset Management LP Point72 Asset Management LP	37,092	$46,470.23	$111,646.92	$65,176.69	140.25%
Kyle P. Smith NewEdge Wealth LLC	116,006	$425,735.69	$432,702.38	$6,966.69	1.64%
Li Peng China Universal Asset Management Co. Ltd.	10,083	$15,402.74	$26,719.95	$11,317.21	73.48%
Hui Fai Tam Caitong International Asset Management Co. Ltd.	35	$64.9	$110.6	$45.7	70.42%
MA Marie-Andree Alain Federation des caisses Desjardins du Quebec	4,500	$8,550	$13,545	$4,995	58.42%
Hager Investment Management Services LLC HAGER INVESTMENT MANAGEMENT SERVICES, LLC	5,000	$7,300	$13,250	$5,950	81.51%
Scott Schroeder Longaeva Partners LP	353,582	$784,951.97	$1.06M	$279,329.85	35.59%
GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.	1,226	$1,803.84	$4,572.98	$2,769.14	153.51%